Text Messaging to Improve Adherence To Repeat Colonoscopy In a Veterans Affairs (VA) Hospital

Colorectal Cancer Clinical Trial

Official title:

Text Messaging to Improve Adherence To Repeat Colonoscopy In The VA: A Pilot Study

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT06185374
• Other study ID #: 23-00583
• Status: Not yet recruiting
• Phase: N/A
• Start date: January 2024
• Est. completion date: May 2024

Study information

• Verified date: December 2023
• Source: NYU Langone Health
• Contact: Peter Liang, MD
• Phone: (212)686-7500
• Email: peter.liang[@]nyulangone.org
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Colorectal cancer is a common but preventable condition, and increasing colorectal cancer screening is one of the most impactful public health contributions in the field of gastroenterology. Text messaging is a simple, cheap, and rapid method to reach patients that may improve adherence to colonoscopy appointments as well as simplify the process of bowel preparation. The purpose of the study is to evaluate the feasibility of a pilot bidirectional text messaging intervention on attendance for screening/surveillance colonoscopy and bowel preparation quality at an urban VA hospital. The goal is to improve adherence to colonoscopy among patients who are due for a repeat colonoscopy.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 50
• Est. completion date: May 2024
• Est. primary completion date: April 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 45 Years to 85 Years

Eligibility

Inclusion Criteria:

• Has previously undergone a colonoscopy and is currently due for a repeat screening or surveillance colonoscopy at the VA.

Exclusion Criteria:

• Patients not due for screening or surveillance colonoscopy. This will be based on 2020 guidelines from the U.S. Multi-Society Task Force on Colorectal Cancer.

• Patients with personal history of colorectal cancer (CRC)/inflammatory bowel disease/ hereditary colon cancer syndrome or family history of hereditary colon cancer syndrome. These criteria will be determined based on ICD9/10 codes or the medical record.

Related Conditions & MeSH terms

• Colorectal Cancer
• Colorectal Neoplasms

Intervention

Behavioral:
• Text Message Instructions/Motivation
For instructional messages, earlier messages will remind patients of the colonoscopy appointment and later messages will help patients complete the bowel preparation process in real-time. Motivational messages will be sent along with instructional messages.

Locations

Country	Name	City	State
United States	New York Harbor Health Care System - Department of Veterans Affairs	New York	New York

Sponsors (2)

Lead Sponsor	Collaborator
NYU Langone Health	National Cancer Institute (NCI)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	National Annie Colonoscopy Survey Score	7-item assessment of participant satisfaction with the "Annie" text intervention. Items are rated on a 5-point scale from 1 (strongly disagree) to 5 (strongly agree). The total score is the sum of responses and ranges from 7 to 35; higher scores indicate greater satisfaction with the intervention.	Day 21 (Up to 7 Days Post-Procedure)
Secondary	Percentage of Participants who Attend Scheduled Colonoscopy Appointment	Assessed via patient's electronic health record.	Up to Day 14
Secondary	Percentage of Participants who Had Adequate Bowel Preparation at Colonoscopy Appointment	Assessed via patient's electronic health record.	Up to Day 14